News · 26 weeks75+75%
2026-03-012026-08-23
Mix3790d
- Insider23(62%)
- SEC Filings6(16%)
- Other4(11%)
- Earnings2(5%)
- Leadership1(3%)
- Analyst1(3%)
Latest news
25 items- PRNew At-Home Surity™ Urinary Management System Designed to Provide Comfort and Reliable Care for People Living with Urinary IncontinenceNew system completes the Surity™ portfolio of external catheters for both men and women Integrates into daily routines to help support management of urinary incontinence at homeDesigned to operate quietly overnight, new Surity™ System helps minimize nighttime interruptions to support comfort and rest MÖLNDAL, Sweden, Aug. 19, 2026 /PRNewswire/ -- Wellspect HealthCare today announced the U.S. launch of the Surity™ Urinary Management System, a discreet at-home urine collection device designed to support people living with urinary incontinence and those who help care for them. This completes the full Surity™ portfolio in the U.S., following the introduction of the Surity™ Female and Male Extern
- INSIDEREVP & CFO Fortson John C. was granted 24,014 shares (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERSVP, CHRO Frohning Andrea L. covered exercise/tax liability with 802 shares, decreasing direct ownership by 1% to 63,191 units (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- SECAmendment: DENTSPLY SIRONA Inc. filed SEC Form 8-K: Financial Statements and Exhibits, Results of Operations and Financial Condition8-K/A - DENTSPLY SIRONA Inc. (0000818479) (Filer)
- SECSEC Form 10-Q filed by DENTSPLY SIRONA Inc.10-Q - DENTSPLY SIRONA Inc. (0000818479) (Filer)
- SECDENTSPLY SIRONA Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - DENTSPLY SIRONA Inc. (0000818479) (Filer)
- PRDentsply Sirona Reports Second Quarter 2026 ResultsNews Summary Reported net sales of $898 millionDelivered GAAP gross margin of 54.9%, GAAP diluted earnings per share of $0.18Achieved adjusted gross margin of 56.4%, adjusted EBITDA margin of 21.3%, adjusted EPS of $0.52Announced expanded partnership with Medline Sinclair, broadening access to Connected Technology Solutions portfolio across CanadaRepurchased 1.3 million shares of common stock during the quarterReiterates 2026 outlook for net sales and adjusted EPS CHARLOTTE, N.C., Aug. 06, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced its financial results for the second quarter of 2026. "2026 continues to be a year of d
- PRDentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair RelationshipCHARLOTTE, N.C., July 28, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona, the world's largest diversified manufacturer of professional dental products and technologies, today announced an expansion of its long-standing relationship with Medline Sinclair, one of Canada's leading full-service dental distributors. Effective September 1, 2026, Medline Sinclair will begin offering Dentsply Sirona's technology portfolio across Canada, building on a successful relationship that has historically focused on consumables. The expanded relationship increases access to Dentsply Sirona's digital dentistry solutions through Medline Sinclair's nationwide network of sales, service teams, and technical specialis
- INSIDERSEC Form 3 filed by new insider Fortson John C.3 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- PRDentsply Sirona to Host Second Quarter Conference Call on August 6thCHARLOTTE, N.C., July 21, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, August 6, 2026, at 4:30 p.m. ET to review its second quarter 2026 financial results. Financial earnings materials will be made available on the Investors section of the Company’s website at https://investor.dentsplysirona.com prior to the call. Conference Call / Webcast Information The live webcast link and call information will be available on the Investors section of the Company’s website at https://investor.dentsplysirona.com. For those planning to participate on t
- ANALYSTBMO Capital Markets initiated coverage on Dentsply Sirona with a new price targetBMO Capital Markets initiated coverage of Dentsply Sirona with a rating of Market Perform and set a new price target of $12.00
- PRPDS Health Surpasses Five Million CEREC Chairside Restorations with Dentsply Sirona, Marking a Major Milestone in Scaled Digital DentistryCHARLOTTE, N.C., July 01, 2026 (GLOBE NEWSWIRE) -- PDS Health® and Dentsply Sirona today announced that PDS Health practices have surpassed five million CEREC chairside restorations, a milestone that underscores the scale, consistency and long-term integration of digital restorative workflows across supported practices nationwide. More than a numerical achievement, the milestone reflects years of sustained clinician adoption and daily use of digital restorative technology in real-world practice settings. It also reinforces PDS Health’s position as one of the highest-volume users of chairside CAD/CAM technology with more than 1,200 CEREC systems installed across its practices. This extensi
- INSIDERSEC Form 4 filed by Director Mazelsky Jonathan Jay4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- SECSEC Form S-8 filed by DENTSPLY SIRONA Inc.S-8 - DENTSPLY SIRONA Inc. (0000818479) (Filer)
- INSIDERAmendment: Director Mazelsky Jonathan Jay bought $101,400 worth of shares (10,000 units at $10.14), increasing direct ownership by 19% to 61,669 units (SEC Form 4)4/A - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERNew insider Barton-Brobst Lindi Rene claimed ownership of 45,440 shares (SEC Form 3)3 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERDirector Hosein Clyde bought $64,902 worth of shares (6,500 units at $9.98), increasing direct ownership by 10% to 70,575 units (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERDirector Mckeon Brian P bought $101,200 worth of shares (10,000 units at $10.12) (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERDirector Gladden Brian T bought $100,000 worth of shares (9,985 units at $10.02), increasing direct ownership by 19% to 61,849 units (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERDirector Mazelsky Jonathan Jay was granted 10,000 shares, increasing direct ownership by 19% to 61,669 units (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERDirector Holden Betsy D bought $99,692 worth of shares (10,086 units at $9.88), increasing direct ownership by 13% to 87,528 units (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERDirector Barber Michael J bought $150,005 worth of shares (15,175 units at $9.88), increasing direct ownership by 37% to 55,943 units (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- SECDENTSPLY SIRONA Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - DENTSPLY SIRONA Inc. (0000818479) (Filer)
- PRDentsply Sirona Appoints John Fortson as Chief Financial OfficerCHARLOTTE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the appointment of John Fortson as Executive Vice President (EVP) and Chief Financial Officer (CFO), effective July 20. Mr. Fortson joins Dentsply Sirona with more than 25 years of leadership experience in finance, operations, and strategy across both public and private equity-backed companies. He has served for 13 years as either CFO or Chief Executive Officer of global manufacturing and industrial businesses. Throughout his career, he has executed large-sc
- INSIDERDirector Lucier Gregory T received a gift of 38,382 shares, was granted 38,382 shares and gifted 38,382 shares (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
XRAY FAQ
7 questionsWhat does DENTSPLY SIRONA Inc. do?
DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression and restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The...Where does XRAY stock trade?
DENTSPLY SIRONA Inc. (XRAY) is listed on NASDAQ.What sector and industry is XRAY in?
DENTSPLY SIRONA Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did DENTSPLY SIRONA Inc. go public?
DENTSPLY SIRONA Inc. (XRAY) completed its IPO in 1987.What are analysts saying about XRAY?
DENTSPLY SIRONA Inc. has had 8 recent analyst actions on file. The most recent action was from BMO Capital Markets: Market Perform with a $1200.00 price target on 2026-07-09. Recent price targets range from $1000.00 to $2000.00.What companies are similar to XRAY?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare XRAY side-by-side with any of them on Quantisnow.How can I track XRAY on Quantisnow?
Quantisnow aggregates DENTSPLY SIRONA Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow XRAY to receive live email and push alerts on every new disclosure.